In the first real-world test of vaccine boosters specially designed to protect against the omicron variant, Israeli researchers have found that people 65 and over who got an updated jab
In the first real-world test of vaccine boosters specially designed to protect against the omicron variant, Israeli researchers have found that people 65 and over who got an updated jab
In the first real-world test of vaccine boosters specially designed to protect against the omicron variant, Israeli researchers have found that people 65 and over who got an updated jab
A preliminary study finds that seniors who received an Omicron-targeting booster shot were 81% less likely to be hospitalized with COVID-19 than those who skipped it.